Abbott Laboratories (NYSE: ABT) announced Monday that Health Canada authorized use of FreeStyle Libre system, a sensor-based glucose monitoring technology, in hospital setting during the COVID-19 pandemic. Monitoring devices are useful in that ..

On Wednesday, Abbott Laboratories (NYSE: ABT) announced its financial results for the third quarter of 2017, with both earnings and revenue beating estimates. Shares of the company increased 1.6% in morning trade on Wednesday.According to the compan..